Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Mycophenolate Mofetil

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 177Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Hetero Labs`s Generics Mycophenolate Mofetil Receives Approval in US
    Hetero Labs`s Generics Mycophenolate Mofetil Receives Approval in US

    22 Oct 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208119

    FDA
    22 Oct 2024
    Share Share
    Azurity Pharmaceuticals' MYHIBBIN™ gets FDA approval.
    Azurity Pharmaceuticals' MYHIBBIN™ gets FDA approval.

    06 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/azurity-pharmaceuticals-inc-announces-fda-approval-of-myhibbin-mycophenolate-mofetil-oral-suspension-302136879.html

    PR NEWSWIRE
    06 May 2024
    Share Share
    Aurobindo Pharma's Generic Mycophenolate Mofetil Receives Approval in the U.S.
    Aurobindo Pharma's Generic Mycophenolate Mofetil Receives Approval in the U.S.

    20 Feb 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217937

    FDA
    20 Feb 2024
    Share Share
    Enforcement Report - Week of November 15, 2023
    Enforcement Report - Week of November 15, 2023

    15 Nov 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-15-2023-17266.pdf

    FDA
    15 Nov 2023
    Share Share
    Strides Pharma arm gets USFDA nod for generic Mycophenolate Mofetil oral sus
    Strides Pharma arm gets USFDA nod for generic Mycophenolate Mofetil oral sus

    31 Aug 2023

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/strides-pharma-arm-gets-usfda-nod-for-generic-mycophenolate-mofetil-oral-suspension/articleshow/103203898.cms

    ECONOMICTIMES
    31 Aug 2023
    Share Share
    Amneal Pharma's Generic Mycophenolate Mofetil Receives Approvals in US
    Amneal Pharma's Generic Mycophenolate Mofetil Receives Approvals in US

    03 Nov 2021

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214871

    FDA
    03 Nov 2021
    Share Share